Peter Friedl Insider Profile
4 Followers
Peter Friedl, Director at CytoTools AG, holds ― shares in CytoTools AG (Ticker: DE:T5O). Most recently, Peter Friedl Sold 500 shares of CytoTools AG on Nov 19, 2020 for an estimated value of €12.96K.
Peter Friedl's Trading History
| T5OCytoTools AG | Nov 19, 2020 | Director | Informative Sell | 12.96K | ― | |||||||||||||||||||||||||||||||||||||||||||
DE:T5O
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Peter Friedl insider profile FAQ
What is the percentage of profitable transactions made by Peter Friedl?
The percentage of profitable transactions made by Peter Friedl is 100%.
What is the average return per transaction made by Peter Friedl?
The average return per transaction made by Peter Friedl is 45.10%.
What stocks does Peter Friedl hold?
Peter Friedl holds: DE:T5O stocks.
What was Peter Friedl’s latest transaction?
Peter Friedl’s latest transaction was an Informative Sell of €12.96K.
What was Peter Friedl's most profitable transaction?
Peter Friedl’s most profitable transaction was an Informative Sell of DE:T5O stock on November 19, 2020. The return on the trade was 63.80%.
What is Peter Friedl's role in CytoTools AG?
Peter Friedl's role in CytoTools AG is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
